一种新的血管造影评分系统可预测孤立性股总动脉内膜切除联合股深动脉成形术后的改善
结果显示股深动脉狭窄评分与6个月临床改善及30天和6个月ABI改善相关,股深动脉病变长度评分与30天临床改善相关,评分系统内部一致性信度高。
要点
- 股深动脉狭窄评分与6个月临床改善相关(P=0.04),与30天和6个月ABI改善相关(r=0.73,P=0.01;r=0.82,P=0.007)。
- 股深动脉病变长度评分与30天临床改善相关(P=0.002),评分≥1.5者100%改善 vs <1.5者67%(P=0.04)。
- 血管造影评分未显示与再次干预、大截肢或死亡相关。
核心结论
- 该机构血管造影评分系统成功预测CFEP术后临床改善。
- 较高的股深动脉狭窄评分和股深动脉病变长度评分对6个月内手术成功最具预测价值。
- 未来需在更大样本和更长周期中验证这些结果。
研究设计与样本
- 术前血管造影由4名盲法外科医生从股深动脉狭窄、股深动脉病变长度和流出道病变严重程度3个域进行定量评估。
- 采用Cronbach α计算评分者内部一致性信度,使用McNemar检验、组间t检验、Pearson相关和线性回归分析。
主要发现
- 88%的患者(n=22)在30天时有临床改善,其余12%的患者(n=3)需要进一步干预。
- 1例患者(4%)在30天至6个月间因孤立性CFEP后 initially 缓解的静息痛复发而需要大截肢,研究期间死亡率为0%。
- 30天时平均ABI增加0.15±0.21,6个月时增加0.06±0.21。
- 股深动脉狭窄评分≥2.6者6个月临床改善比例为64%,<2.6者为15%(P=0.15)。
- 股深动脉病变长度评分≥1.5者30天临床改善比例为100%,<1.5者为67%(P=0.04)。
关键数值与推荐
- 股深动脉狭窄评分与6个月临床改善相关(P=0.04)。
- 股深动脉狭窄评分与30天ABI改善相关(r=0.73,P=0.01),与6个月ABI改善相关(r=0.82,P=0.007)。
- 股深动脉病变长度评分与30天临床改善相关(P=0.002)。
- 血管造影评分未发现与再次干预、大截肢或死亡相关。
临床怎么用
- 原文未据此给出推荐。
局限性
- 未来需在更大样本和更长周期中验证这些结果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Numerous angiography-based peripheral arterial disease classification schemes have been developed to stratify severity of preoperative patient disease, but few studies have correlated angiography-based anatomic classification schemes to postoperative outcomes. This study examined whether a proposed pre-operative angiography scoring system was predictive of outcomes after isolated common femoral endarterectomy with profundaplasty (CFEP). METHODS: A retrospective review was conducted of patients treated with isolated CFEP for claudication and/or rest pain at a single institution from 2016-19. Pre-operative angiograms were assessed quantitatively by 4 blinded surgeons across 3 domains: profunda stenosis, profunda disease length, and outflow disease severity. Table I describes the proposed angiography scoring system. Internal consistency reliability of rater scores was calculated using Cronbach alpha. Outcomes included clinical improvement, further interventions, major amputations, mortality, and mean increase in ankle-brachial index (ABI) at 30 days, and 6 months. McNemar tests, between-group t-tests, Pearson correlations, and linear regression were used. RESULTS: Clinical Outcomes 88% of patients (n = 22) had clinical improvement at 30 days; the remaining 12% of patients (n = 3) required further interventions. One patient (4%) required major amputation between 30 days and 6 months for recurrence of rest pain that had initially resolved after isolated CFEP. There was 0% mortality during the study period. Mean ABI increased by 0.15 ± 0.21 at 30 days, and by 0.06 ± 0.21 at 6 months. Angiography Scoring System Profunda stenosis score was associated with clinical improvement at 6 months (P = 0.04). A profunda stenosis score of ≥2.6 was strongly associated with 6-month clinical improvement (64% of those ≥ 2.6 improved, versus 15% of those <2.6, P = 0.15). Profunda stenosis score was associated with ABI improvement at 30 days (r = 0.73, P = 0.01) and 6 months (r = 0.82, P = 0.007). Profunda disease length score was associated with clinical improvement at 30 days (P = 0.002). 100% of patients with a profunda disease length score of ≥1.5 clinically improved at 30 days, versus 67% of those with <1.5 (P = 0.04). Angiography scores were not found to be associated with further intervention, major amputation, or mortality. Cronbach alpha for profunda stenosis, profunda disease length, and outflow severity scores were 0.90, 0.90, and 0.79, respectively, indicating strong internal consistency. CONCLUSIONS: This institutional angiography scoring system successfully predicts clinical improvement following CFEP. Higher profunda stenosis and profunda disease length scores were most predictive of operative success within 6 months. Future validation studies will investigate these outcomes in a larger population, and over a longer period.
引用
- Rodriguez S, Mangipudi S, Pomy BJ, et al. A Novel Angiography Scoring System Predicts Improvement After Isolated Common Femoral Endarterectomy With Profundaplasty. Ann Vasc Surg. 2021. PMID: 34743008. doi:10.1016/j.avsg.2021.08.046
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。